NewsBenzingaResMed、2027年度調整後EPSを12.00~12.25ドルと予想、予想12.09ドルを上回る 売上高は57.5億~58.5億ドルを見込む、予想58.14億ドルを下回る ResMed、2027年度調整後EPSを12.00~12.25ドルと予想、予想12.09ドルを上回る 売上高は57.5億~58.5億ドルを見込む、予想58.14億ドルを下回る Benzinga 2026.10.29 21:31 (GMT+0) Open on Benzinga Other news Hearing Nvidia Chair Says Jensen Huang Not Coming Back Here’s How Much You Would Have Made Owning KLA Stock In The Last 20 Years Freedom Broker Maintains Buy on Euroseas, Raises Price Target to $96 Sam Altman says his life is so weird that he’s unphased by Andrew Garfield portraying him in upcoming movie Freedom Broker Maintains Buy on JD.com, Lowers Price Target to $40 I Used This Options Strategy to Profit from the Post-IPO Plunge in SpaceX. Now I’ll Use It Again on ANT Stock After Anthropic Starts Trading.
Sam Altman says his life is so weird that he’s unphased by Andrew Garfield portraying him in upcoming movie
I Used This Options Strategy to Profit from the Post-IPO Plunge in SpaceX. Now I’ll Use It Again on ANT Stock After Anthropic Starts Trading.